Both in Pharmaceuticals
CDT Equity vs Artelo Biosciences
Over the past year CDT returned −100.0% and ARTL returned −97.6%; their daily moves had a correlation of -0.18.
CDT −100.0% ARTL −97.6%Growth of $1, one year, split-adjusted
| Metric | CDT | ARTL |
|---|---|---|
| Price | $0.0830 | $2.33 |
| Market cap | $64.0K | $1.3M |
| Today | +3.75% | +5.91% |
| 1 month | −94.3% | −42.8% |
| 6 months | −100.0% | −92.4% |
| Year to date | −100.0% | −92.9% |
| 1 year | −100.0% | −97.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 992.3% | 650.2% |
| Short % of float | 18.8% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).